Pharmaceuticals microencapsulated by vapor deposited polymers and method
AssigneeRonald T. Dodge Co.
InventorRonald J. Versic
Life of this patent
Estimating the term…
Abstract
A microencapsulated pharmaceutical is formed by vapor depositing a polymeric film about an active pharmaceutical agent. The film thickness of the vapor deposited film is controlled to provide effective controlled release of said pharmaceutical agent subsequent to application. In a preferred embodiment the pharmaceutical is an orally ingestible pharmaceutical formed by vapor deposition of a poly-p-xylylene polymer about a core comprising an active pharmaceutical agent. The pharmaceutical agent exhibits surprising controlled release activity inspite of the extreme inertness of vapor deposited films such as Parylene films.
Claims3
A pharmaceutical comprising:
- an active pharmaceutical agent coated with a vapor deposited inert polymeric film produced by chemical vapor deposition, said inert polymeric film comprising the solid polymerization product of pyrolyzed vapors of di-p-xylylene, said product having the general repeating units ##STR3## wherein R is an aromatic nuclear substituent, X is a number from 0 to 3 and n is a number from 10-10,000,
- said inert polymeric film having a thickness of from about 0.1 to about 10 microns, and
- said active pharmaceutical agent being selected from a group consisting of ammonium bisphosphate, ammonium chloride, theophylline, erythromycin, aspirin, colchicine, diethylstilbestrol, digestive enzymes, ferrogylcine sulphate, methenaminemaleate, oxbile extract, paraminosalicyclic acid, phenazopyridiene, proteolitic enzymes, potassium chloride, potassium iodide, potassium salicylate, sodium acid pyrophosphate, sodium amino benzoate, sodium biphosphate, sodium chloride, sodium salicylate, sulfacsalazine, sulfoxone sodium, thyroid, and ascorbic acid.
Dependencies are inferred from the claim text.